Prescription drug · NDA AUTHORIZED GENERIC
Calcipotriene and Betamethasone Dipropionate NDC 66993-938
Calcipotriene monohydrate 50 ug/g; Betamethasone dipropionate .5 mg/g · Ointment · Topical · Prasco Laboratories
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 66993-938-61 | 6699309386166993093861 | 1 TUBE in 1 CARTON (66993-938-61) / 60 g in 1 TUBEMarketed from Jan 28, 2020 | |
| 66993-938-65 | 6699309386566993093865 | 1 TUBE in 1 CARTON (66993-938-65) / 100 g in 1 TUBEMarketed from Jan 28, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Calcipotriene and Betamethasone Dipropionate
- Generic name (nonproprietary)
- calcipotriene and betamethasone dipropionate
- Active ingredients
- Calcipotriene monohydrate — 50 ug/gBetamethasone dipropionate — .5 mg/g
- Dosage form
- Ointment
- Route
- Topical
- Labeler
- Prasco LaboratoriesNDC labeler code 66993
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 021852
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)Vitamin D (Chemical structure)
- Identifiers
- Product ID 66993-938_aad74639-2667-44ea-9d2b-32a5dd5ea596SPL ID aad74639-2667-44ea-9d2b-32a5dd5ea596SPL set ID d9493e66-251c-426c-90a8-1bf1e526ab85RxCUI 388525UNII S7499TYY6G, 826Y60901U
- Pharmacologic class
- Corticosteroid; Vitamin D Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N466993093861followed by a unit qualifier and the quantityPackage 66993-0938-61. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Calcipotriene and Betamethasone Dipropionate Ointment is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. Calcipotriene and Betamethasone Dipropionate Ointment is a vitamin D analogue and corticosteroid combination product indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 66993-938
- What is NDC 66993-938?
- 66993-938 is the product NDC for Calcipotriene and Betamethasone Dipropionate, Calcipotriene monohydrate 50 ug/g; Betamethasone dipropionate .5 mg/g ointment, listed with the FDA by Prasco Laboratories. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Calcipotriene and Betamethasone Dipropionate.
- What is the active ingredient?
- Calcipotriene monohydrate, Betamethasone dipropionate.
- Who is the labeler?
- Prasco Laboratories, NDC labeler code 66993. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Calcipotriene and Betamethasone Dipropionate?
- 6 other product NDCs are listed under this name. See all Calcipotriene and Betamethasone Dipropionate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Calcipotriene and Betamethasone Dipropionate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| calcipotriene and betamethasone dipropionate | Betamethasone dipropionate .5 mg/g; Calcipotriene 50 ug/g | SuspensionTopical | Cosette Pharmaceuticals, Inc. | 0713-0848 | 00713-0848-6000713-0848-92 |
| Calcipotriene and Betamethasone Dipropionate | Calcipotriene 50 ug/g; Betamethasone dipropionate 50 mg/g | SuspensionTopical | Sun Pharmaceutical Industries, Inc. | 51672-1402 | 51672-1402-0451672-1402-08 |
| Calcipotriene and Betamethasone Dipropionatecalcipotriene, betamethasone dipropionate | Calcipotriene 50 ug/g; Betamethasone dipropionate .643 mg/g | OintmentTopical | Padagis Israel Pharmaceuticals Ltd | 45802-816 | 45802-0816-0145802-0816-96 |
| Calcipotriene and Betamethasone Dipropionatecalcipotriene, betamethasone dipropionate | Calcipotriene 50 ug/g; Betamethasone dipropionate .643 mg/g | OintmentTopical | Bryant Ranch Prepack | 63629-2520 | 63629-2520-01 |
| Calcipotriene and Betamethasone Dipropionatecalcipotriene, betamethasone dipropionate | Calcipotriene 50 ug/g; Betamethasone dipropionate .643 mg/g | OintmentTopical | Bryant Ranch Prepack | 63629-8617 | 63629-8617-01 |
| Calcipotriene and Betamethasone Dipropionatecalcipotriene, betamethasone dipropionate | Calcipotriene 50 ug/g; Betamethasone dipropionate .643 mg/g | OintmentTopical | Bryant Ranch Prepack | 72162-1428 | 72162-1428-0172162-1428-06 |